333 related articles for article (PubMed ID: 27990610)
1. Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
Machida K
Hepatol Int; 2017 Mar; 11(2):143-147. PubMed ID: 27990610
[TBL] [Abstract][Full Text] [Related]
2. Road to stemness in hepatocellular carcinoma.
Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
[TBL] [Abstract][Full Text] [Related]
3. Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus.
Machida K
Drug Deliv Transl Res; 2013 Apr; 3(2):152-64. PubMed ID: 25787983
[TBL] [Abstract][Full Text] [Related]
4. Dysadherin can enhance tumorigenesis by conferring properties of stem-like cells to hepatocellular carcinoma cells.
Park JR; Kim RJ; Lee YK; Kim SR; Roh KJ; Oh SH; Kong G; Kang KS; Nam JS
J Hepatol; 2011 Jan; 54(1):122-31. PubMed ID: 20952084
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
Jayachandran A; Dhungel B; Steel JC
J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
[TBL] [Abstract][Full Text] [Related]
6. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
[TBL] [Abstract][Full Text] [Related]
7. Pluripotency Transcription Factors and Metabolic Reprogramming of Mitochondria in Tumor-Initiating Stem-like Cells.
Machida K
Antioxid Redox Signal; 2018 Apr; 28(11):1080-1089. PubMed ID: 29256636
[No Abstract] [Full Text] [Related]
8. Sox9 regulates self-renewal and tumorigenicity by promoting symmetrical cell division of cancer stem cells in hepatocellular carcinoma.
Liu C; Liu L; Chen X; Cheng J; Zhang H; Shen J; Shan J; Xu Y; Yang Z; Lai M; Qian C
Hepatology; 2016 Jul; 64(1):117-29. PubMed ID: 26910875
[TBL] [Abstract][Full Text] [Related]
9. Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.
Shan J; Shen J; Liu L; Xia F; Xu C; Duan G; Xu Y; Ma Q; Yang Z; Zhang Q; Ma L; Liu J; Xu S; Yan X; Bie P; Cui Y; Bian XW; Qian C
Hepatology; 2012 Sep; 56(3):1004-14. PubMed ID: 22473773
[TBL] [Abstract][Full Text] [Related]
10. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy.
Franceschi S; Montella M; Polesel J; La Vecchia C; Crispo A; Dal Maso L; Casarin P; Izzo F; Tommasi LG; Chemin I; Trépo C; Crovatto M; Talamini R
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):683-9. PubMed ID: 16614109
[TBL] [Abstract][Full Text] [Related]
12. Origin of hepatocellular carcinoma: role of stem cells.
Wu XZ; Chen D
J Gastroenterol Hepatol; 2006 Jul; 21(7):1093-8. PubMed ID: 16824058
[TBL] [Abstract][Full Text] [Related]
13. Hepatocarcinogenesis: hepatitis viruses and altered tumor suppressor gene function.
Tabor E
Princess Takamatsu Symp; 1995; 25():151-61. PubMed ID: 8875620
[TBL] [Abstract][Full Text] [Related]
14. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
Tornesello ML; Buonaguro L; Tatangelo F; Botti G; Izzo F; Buonaguro FM
Genomics; 2013 Aug; 102(2):74-83. PubMed ID: 23583669
[TBL] [Abstract][Full Text] [Related]
15. Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor-host interaction and clinical course.
Muramatsu S; Tanaka S; Mogushi K; Adikrisna R; Aihara A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Nakayama K; Tanaka H; Yamaoka S; Arii S
Hepatology; 2013 Jul; 58(1):218-28. PubMed ID: 23447025
[TBL] [Abstract][Full Text] [Related]
16. Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected Hepatocytes.
Kwon YC; Bose SK; Steele R; Meyer K; Di Bisceglie AM; Ray RB; Ray R
J Virol; 2015 Nov; 89(22):11549-56. PubMed ID: 26355082
[TBL] [Abstract][Full Text] [Related]
17. Identification of tumor-initiating cells in a canine hepatocellular carcinoma cell line.
Michishita M; Ezaki S; Ogihara K; Naya Y; Azakami D; Nakagawa T; Sasaki N; Arai T; Shida T; Takahashi K
Res Vet Sci; 2014 Apr; 96(2):315-22. PubMed ID: 24534130
[TBL] [Abstract][Full Text] [Related]
18. Cancer Stem cells and their cellular origins in primary liver and biliary tract cancers.
Oikawa T
Hepatology; 2016 Aug; 64(2):645-51. PubMed ID: 26849406
[TBL] [Abstract][Full Text] [Related]
19. Liver cancer: the role of stem cells.
Alison MR; Lovell MJ
Cell Prolif; 2005 Dec; 38(6):407-21. PubMed ID: 16300653
[TBL] [Abstract][Full Text] [Related]
20. All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer.
Zhang Y; Guan DX; Shi J; Gao H; Li JJ; Zhao JS; Qiu L; Liu J; Li N; Guo WX; Xue J; Zhou FG; Wu MC; Wang HY; Xie D; Cheng SQ
J Hepatol; 2013 Dec; 59(6):1255-63. PubMed ID: 23867314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]